# Adult and Adolescent Hemophilia Patients Treated With Marstacimab: a Patient Experience Registry

> **NCT06992076** · — · RECRUITING · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 100 (estimated)

## Conditions studied

- Hemophilia

## Interventions

- **DRUG:** Marstacimab

## Key facts

- **NCT ID:** NCT06992076
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-15
- **Primary completion:** 2027-08-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06992076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06992076, "Adult and Adolescent Hemophilia Patients Treated With Marstacimab: a Patient Experience Registry". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06992076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*